AQP4 and Stroke: In the present study, acute inhibition of AQP4 using TGN-020 decreased the edema and infarct lesion volume 1day post-stroke, attenuated peri-infarct astrogliosis, AQP4 depolarization, and infarct lesion volume, promoting neurological recovery at 14 days post-stroke.